Literature DB >> 26667168

Protein Inhibitor of Activated STAT3 Regulates Migration, Invasion, and Activation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis.

Minxi Lao1, Maohua Shi1, Yaoyao Zou1, Mingcheng Huang1, Yujin Ye1, Qian Qiu1, Youjun Xiao1, Shan Zeng1, Liuqin Liang1, Xiuyan Yang1, Hanshi Xu2.   

Abstract

The aggressive phenotype displayed by fibroblast-like synoviocytes (FLSs) is a critical factor of cartilage destruction in rheumatoid arthritis (RA). Increased FLSs migration and subsequent degradation of the extracellular matrix are essential to the pathology of RA. Protein inhibitor of activated STAT (PIAS), whose family members include PIAS1, PIAS2 (PIASx), PIAS3, and PIAS4 (PIASy), play important roles in regulating various cellular events, such as cell survival, migration, and signal transduction in many cell types. However, whether PIAS proteins have a role in the pathogenesis of RA is unclear. In this study, we evaluated the role of PIAS proteins in FLSs migration, invasion, and matrix metalloproteinases (MMPs) expression in RA. We observed increased expression of PIAS3, but not PIAS1, PIAS2, or PIAS4, in FLSs and synovial tissues from patients with RA. We found that PIAS3 knockdown by short hairpin RNA reduced migration, invasion, and MMP-3, MMP-9, and MMP-13 expression in FLSs. In addition, we demonstrated that PIAS3 regulated lamellipodium formation during cell migration. To gain insight into molecular mechanisms, we evaluated the effect of PIAS3 knockdown on Rac1/PAK1 and JNK activation. Our results indicated that PIAS3-mediated SUMOylation of Rac1 controlled its activation and modulated the Rac1 downstream activity of PAK1 and JNK. Furthermore, inhibition of Rac1, PAK1, or JNK decreased migration and invasion of RA FLSs. Thus, our observations suggest that PIAS3 suppression may be protective against joint destruction in RA by regulating synoviocyte migration, invasion, and activation.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26667168     DOI: 10.4049/jimmunol.1403254

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Rheumatoid arthritis: PIAS3 inhibition blocks FLS activity.

Authors:  João H Duarte
Journal:  Nat Rev Rheumatol       Date:  2016-01-05       Impact factor: 20.543

2.  Indirubin inhibits the migration, invasion, and activation of fibroblast-like synoviocytes from rheumatoid arthritis patients.

Authors:  Mingcheng Huang; Lihui Wang; Shan Zeng; Qian Qiu; Yaoyao Zou; Maohua Shi; Hanshi Xu; Liuqin Liang
Journal:  Inflamm Res       Date:  2017-03-06       Impact factor: 4.575

Review 3.  The role of the JAK/STAT signal pathway in rheumatoid arthritis.

Authors:  Charles J Malemud
Journal:  Ther Adv Musculoskelet Dis       Date:  2018-05-19       Impact factor: 5.346

4.  CYTL1 inhibits tumor metastasis with decreasing STAT3 phosphorylation.

Authors:  Xiaolin Wang; Ting Li; Yingying Cheng; Pingzhang Wang; Wanqiong Yuan; Qiyao Liu; Fan Yang; Qiang Liu; Dalong Ma; Shigang Ding; Jun Wang; Wenling Han
Journal:  Oncoimmunology       Date:  2019-02-18       Impact factor: 8.110

5.  Silence of S1PR4 Represses the Activation of Fibroblast-like Synoviocytes by Regulating IL-17/STAT3 Signaling Pathway.

Authors:  Pengyu Zhang; Qiang Zhang; Zhenxia Shao
Journal:  Inflammation       Date:  2022-09-06       Impact factor: 4.657

Review 6.  Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway.

Authors:  Linlin Fan; Xudong Yang; Minying Zheng; Xiaohui Yang; Yidi Ning; Ming Gao; Shiwu Zhang
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

7.  Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer.

Authors:  Mengmeng Jiang; Wenwen Zhang; Rui Zhang; Pengpeng Liu; Yingnan Ye; Wenwen Yu; Xiaojing Guo; Jinpu Yu
Journal:  Oncogene       Date:  2020-05-12       Impact factor: 9.867

8.  Chromatin remodeling: demethylating H3K4me3 of type I IFNs gene by Rbp2 through interacting with Piasy for transcriptional attenuation.

Authors:  Xiaoli Yu; Hui Chen; Chen Zuo; Xi Jin; Yibing Yin; Hong Wang; Mei Jin; Keiko Ozato; Songxiao Xu
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.191

9.  Punicalagin Inhibited Inflammation and Migration of Fibroblast-Like Synoviocytes Through NF-κB Pathway in the Experimental Study of Rheumatoid Arthritis.

Authors:  Mingcheng Huang; Keping Wu; Shan Zeng; Wenfen Liu; Tianjiao Cui; Zhiqing Chen; Lian Lin; Dongying Chen; Hui Ouyang
Journal:  J Inflamm Res       Date:  2021-05-12

10.  The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

Authors:  Chiara Baldini; Francesca Romana Moriconi; Sara Galimberti; Peter Libby; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.